الولايات المتحدة · منصات وبيانات · TipRanks

Pfizer announces results across serotypes in Phase 2 study of 25vPnC

نشره TipRanks · الولايات المتحدة منذ 10 س

Pfizer (PFE) announced detailed results across serotypes from a Phase 2 study for its investigational 25-valent pneumococcal conjugate vaccine candidate, ...

اقرأ المقال كاملًا على TipRanks سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.tipranks.com)

يستحق القراءة أيضًا

The Motley Fool

Vanguard S&P 500 ETF Long-Term Outlook: What Historical Trends Suggest for Patient Investors

Investing.com

Oppenheimer reiterates Amgen stock rating on cancer drug data

MarketBeat

Dr. Reddy's Laboratories Ltd (NYSE:RDY) Stock Has Consensus Target Price of $492.90

Seeking Alpha

Roche lung cancer drug extends survival by nearly six months in late-stage trial

MarketWatch

‘She’s living the dream’: My stepmother said I can buy my childhood home for $850,000. Is she taking advantage of me?

TheStreet